Toxic shock syndrome: Difference between revisions

From IDWiki
m (Aidan moved page Toxic shock syndromes to Toxic shock syndrome over redirect)
No edit summary
 
(5 intermediate revisions by the same user not shown)
Line 1: Line 1:
  +
== Background ==
* Severe septic shock caused by certain bacterial infections
+
* Severe septic shock caused by certain bacterial infections, primarily ''[[Staphylococcus aureus]]'' and ''[[Streptococcus pyogenes]]''
  +
** Caused by superantigens, which non-specifically activate a massive number of T-cells
  +
*Similar syndrome can be caused by toxin production of [[Clostridial toxic shock syndrome|''Clostridium sordelli'']]
   
 
== Criteria ==
 
== Criteria ==
 
 
{| class="wikitable"
 
{| class="wikitable"
 
! Criteria
 
! Criteria
! Staphylococcal
+
! [[Staphylococcal toxic shock syndrome|Staphylococcal]]
! Streptococcal
+
! [[Streptococcal toxic shock syndrome|Streptococcal]]
 
|-
 
|-
 
| Confirmed
 
| Confirmed
Line 57: Line 59:
 
|}
 
|}
   
  +
== Management ==
== Staphylococcal Toxic Shock Syndrome ==
 
  +
{| class="wikitable"
 
  +
!
Source: [https://wwwn.cdc.gov/nndss/conditions/toxic-shock-syndrome-other-than-streptococcal/case-definition/2011/ CDC case definition 2011]
 
  +
!First-Line
 
  +
!Beta-lactam Allergy
=== Clinical Criteria ===
 
  +
!Notes
 
  +
|-
An illness with the following clinical manifestations:
 
  +
|[[Streptococcus pyogenes]]
 
  +
|[[Penicillin G]] and [[clindamycin]]
* '''Fever:''' temperature greater than or equal to 102.0°F (greater than or equal to 38.9°C)
 
  +
|[[Macrolide]] or [[fluoroquinolone]], and [[clindamycin]]
* '''Rash:''' diffuse macular erythroderma
 
  +
|Macrolide and fluoroquinolone resistance increasing
* '''Desquamation:''' 1-2 weeks after onset of rash
 
  +
|-
* '''Hypotension:''' systolic blood pressure less than or equal to 90 mm Hg for adults or less than fifth percentile by age for children aged less than 16 years
 
  +
|MLS-resistant [[Streptococcus pyogenes]]
* '''Multisystem involvement''' (three or more of the following organ systems):
 
  +
|[[Penicillin G]], and [[vancomycin]] or [[teicoplanin]]
** '''Gastrointestinal:''' vomiting or diarrhea at onset of illness
 
  +
|[[Vancomycin]] or [[teicoplanin]]
** '''Muscular:''' severe myalgia or creatine phosphokinase level at least twice the upper limit of normal
 
  +
|Macrolide resistance associated with clindamycin resistance
** '''Mucous membrane:''' vaginal, oropharyngeal, or conjunctival hyperemia
 
  +
|-
** '''Renal:''' blood urea nitrogen or creatinine at least twice the upper limit of normal for laboratory or urinary sediment with pyuria (greater than or equal to 5 leukocytes per high-power field) in the absence of urinary tract infection
 
  +
|Methicillin-susceptible [[Staphylococcus aureus]]
** '''Hepatic:''' total bilirubin, alanine aminotransferase enzyme, or asparate aminotransferase enzyme levels at least twice the upper limit of normal for laboratory
 
  +
|[[Cloxacillin]] or [[nafcillin]] or [[cefazolin]], and [[clindamycin]]
** '''Hematologic:''' platelets less than 100,000/mm3
 
  +
|[[Clarithromycin]] and [[clindamycin]]
** '''Central nervous system:''' disorientation or alterations in consciousness without focal neurologic signs when fever and hypotension are absent
 
  +
|
 
  +
|-
=== Laboratory Criteria for Diagnosis ===
 
  +
|Methicillin-resistant [[Staphylococcus aureus]]
 
  +
|[[Clindamycin]] or [[linezolid]], and [[vancomycin]] or [[teicoplanin]]
Negative results on the following tests, if obtained:
 
  +
|
  +
|
  +
|-
  +
|Glycopeptide resistant or intermediate [[Staphylococcus aureus]]
  +
|[[Linezolid]] and [[clindamycin]] (if susceptible)
  +
|
  +
|Incidence increasing. Geographical patterns highly variable
  +
|}
   
  +
== Further Reading ==
* Blood or cerebrospinal fluid cultures (blood culture may be positive for Staphylococcus aureus)
 
* Negative serologies for Rocky Mountain spotted fever, leptospirosis, or measles
 
   
  +
* Gram-positive toxic shock syndromes. ''Lancet Infect Dis''. 2009;9(5):281-290. doi: [https://doi.org/10.1016/S1473-3099(09)70066-0 10.1016/S1473-3099(09)70066-0]
=== Case Classification ===
 
   
  +
[[Category:Infectious syndromes]]
* Probable: A case which meets the laboratory criteria and in which four of the five clinical criteria described above are present
 
* Confirmed: A case which meets the laboratory criteria and in which all five of the clinical criteria described above are present, including desquamation, unless the patient dies before desquamation occurs
 

Latest revision as of 10:34, 22 November 2022

Background

Criteria

Criteria Staphylococcal Streptococcal
Confirmed hypotension + fever + rash + desquamating + 3 or more other hypotension + 2 or more other
Hypotension SBP ≤90 mmHg SBP ≤90 mmHg
Fever temp ≥38.9ºC
Skin diffuse macular erythroderma followed by desquamation generalized erythematous macular rash that may desquamate
GI n/v/d at onset
Resp ARDS
MSK myalgia ± CK ≥2x ULN soft-tissue necrosis (e.g. nec.fasc)
Mucosa hyperemia of any mucosa
Nephro Creatinine ≥2x ULN, or
pyuria without UTI
Creatinine ≥177 or ≥2x ULN or ≥2x baseline
Hepatic bili/ALT/AST ≥2x ULN ALT/AST/bili ≥2x ULN or ≥2x baseline
Heme thrombocytopenia <100 thrombocytopenia ≤100, or
DIC (INR/fibrinogen/D-dimer)
CNS altered LOC without focal signs

Management

First-Line Beta-lactam Allergy Notes
Streptococcus pyogenes Penicillin G and clindamycin Macrolide or fluoroquinolone, and clindamycin Macrolide and fluoroquinolone resistance increasing
MLS-resistant Streptococcus pyogenes Penicillin G, and vancomycin or teicoplanin Vancomycin or teicoplanin Macrolide resistance associated with clindamycin resistance
Methicillin-susceptible Staphylococcus aureus Cloxacillin or nafcillin or cefazolin, and clindamycin Clarithromycin and clindamycin
Methicillin-resistant Staphylococcus aureus Clindamycin or linezolid, and vancomycin or teicoplanin
Glycopeptide resistant or intermediate Staphylococcus aureus Linezolid and clindamycin (if susceptible) Incidence increasing. Geographical patterns highly variable

Further Reading